Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity
Listen to this summary
The VAPOR 2 study aimed to assess the safety and effectiveness of water vapor therapy for ablating prostate tissue in men with intermediate-risk localized prostate cancer. Initial results from 110 participants indicated that 75% had benign tissue on follow-up biopsy, with a significant reduction in PSA levels and prostate volume, while adverse events were generally mild and resolved without complications. These findings suggest that water vapor therapy may be an effective treatment option with low procedural morbidity for this patient population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More in Urology
View all →Sep 23, 2026 · International urogynecology journal
Alpha-Linolenic Acid and Tarantula Cubensis Extract Attenuate Bladder Inflammation in Cyclophosphamide-Induced Cystitis: A Comparative Experimental Study
Sep 23, 2026 · International urogynecology journal
Surgical Strategies for Apical Pelvic Organ Prolapse: A Systematic Review and Network Meta-Analysis
Sep 23, 2026 · International urogynecology journal
The Surgical Challenge of the Repeat Sacrocolpopexy
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · International urogynecology journal
Comparison of Postoperative Functional Recovery and Anatomical Restoration in Patients with Pelvic Organ Prolapse Undergoing Three Types of Apical Suspension Techniques: A Retrospective Study
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


